What happened
GeneOne Life Science updated the terms of convertible bonds to raise US$11.1M, about 30.9% of its market value.
For context, this raise equals about 30.9% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$11.1M |
| vs. market value | 30.9% |
| Filed | 2026-09-30, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260930000698 → open original filing |
Source: DART. Information only, not investment advice.